A quick overview

PharmaFutures is an investor-led dialogue that explores how to better align corporate profitability with improved access to innovative and affordable healthcare. Read more…

PharmaFutures has run since 2004 and is now in its fifth iteration – Innovation in health systems.

Sophie

Conclusions of the latest PharmaFutures dialogue: Interview with Sophia Tickell, Director of PharmaFutures. Listen here.

Comment

Innovation remains core to our success, ensuring we research and develop new medicines and vaccines which address unmet medical needs. The Shared Value report outlines how all stakeholders including industry, investors, governments and regulators can play their part in ensuring the appropriate balance between value for money and delivering fair rewards for innovation can be achieved.

Simon Jose, GSK

Download Download